Safety and Efficacy of Distal Radial Access (SAFE-BOX)
A Prospective Registry to Assess the Safety and Efficacy of Distal Radial Access (SAFE-BOX)
1 other identifier
observational
3,600
1 country
1
Brief Summary
A Prospective Registry to assess the Safety and Efficacy of Distal Radial Approach
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2023
CompletedFirst Submitted
Initial submission to the registry
March 8, 2023
CompletedFirst Posted
Study publicly available on registry
March 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 24, 2026
April 1, 2026
4 years
March 8, 2023
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Success rate of examination and procedure
Success rate of examination and procedure
through procedure completion, up to 24 hours
Secondary Outcomes (3)
the success rate of the puncture
through procedure completion, up to 24 hours
puncture time
through procedure completion, up to 24 hours
complications of the puncture region
the first outpatient visit after discharge
Eligibility Criteria
Evaluate the success rate of coronary angiography and intervention in patients with palpable radial artery
You may qualify if:
- Patients over 20 years of age
- Patients requiring coronary angiography or intervention
- Patients with palpable distant radial artery
You may not qualify if:
- Patients with distant radial artery too small or not palpable
- Pregnant women
- Patients not appropriate for the researcher to judge
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yongcheol Kim
Yongin, Gyeonggi-do, 16995, South Korea
Study Officials
- STUDY DIRECTOR
Yongcheol Kim, MD, PhD
Severance Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
March 8, 2023
First Posted
March 20, 2023
Study Start
January 5, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 24, 2026
Record last verified: 2026-04